Drugs Made In America Acquisition II Corp.

Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) is a blank-check company that registered its securities under Section 12(b) with an 8-A12B filing dated September 24, 2025, indicating a 2025 IPO. The SPAC is the second vehicle from the Drugs Made In America sponsor group and targets the pharmaceutical and domestic drug manufacturing sector, reflecting continued investor interest in onshoring U.S. medicine supply chains. The unit listing on Nasdaq marks the beginning of its search for a merger partner within the life sciences and pharmaceutical space. Visit SpacDesk and sign up for full data, filings, and deal-tracking on DMIIU and hundreds of other active SPACs.